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Abstract
Reliable and scalable sterilisation of hydrogels is critical to the clinical translation of many biofabrication
approaches, such as extrusion-based 3D bioprinting of cell-laden bio-inks. However sterilisation methods
can be destructive, and may have detrimental effects on the naturally-derived hydrogels that constitute
much of the bio-ink palette. Determining effective sterilisation methods requires detailed analysis of the
effects of sterilisation on relevant properties such as viscosity, printability and cytocompatibility. Yet there
have been no studies specifically exploring the effects of sterilisation on bio-inks to date. In this work, we
explored the effects of various sterilisation techniques on four of the most widely used bio-ink
components: gelatin, gelatin methacryloyl, hyaluronic acid, and hyaluronic acid methacrylate. Autoclaving
was the most destructive sterilisation method, producing large reductions in viscosity and in mechanical
properties following crosslinking. Filter sterilisation caused some reduction in rheological properties of
GelMA due to removal of higher molecular weight components, but did not affect photocrosslinking.
Ethylene oxide (EtO) was the least destructive sterilisation method in terms of rheological properties for
all materials, had no detrimental effect on the photocrosslinkable methacrylate/methacrylamide groups,
and so was chosen for more detailed examination. In biological analyses, we found that EtO treatment
successfully eradicated a bacterial challenge of E. coli, caused no decrease in viability of human
mesenchyman stem cells (hMSCs), and had no effect on their rate of proliferation. Finally, we found that
EtO-treated hydrogels supported encapsulated hMSCs to differentiate towards the chondrogenic lineage,
and to produce new cartilage matrix. Our results bring to light various effects that sterilisation can have
on bio-inks, as well as highlighting EtO sterilisation as a method which minimises degradation of
properties, while still promoting biological function.
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Abstract (<300 words)
Reliable and scalable sterilisation of hydrogels is critical to the clinical translation of many
biofabrication approaches, such as extrusion-based 3D bioprinting of cell-laden bio-inks.
However sterilisation methods can be destructive, and may have detrimental effects on the
naturally-derived hydrogels that constitute much of the bio-ink palette. Determining effective
sterilisation methods requires detailed analysis of the effects of sterilisation on relevant
properties such as viscosity, printability and cytocompatibility. Yet there have been no studies
specifically exploring the effects of sterilisation on bio-inks to date.
In this work, we explored the effects of various sterilisation techniques on four of the most
widely used bio-ink components: gelatin, gelatin methacryloyl, hyaluronic acid, and hyaluronic
acid methacryloyl. Autoclaving was the most destructive sterilisation method, producing large
reductions in viscosity and in mechanical properties following crosslinking. Filter sterilisation
caused some reduction in rheological properties of GelMA due to removal of higher molecular
weight components, but did not affect photocrosslinking. Ethylene oxide (EtO) was the least
destructive sterilisation method in terms of rheological properties for all materials, had no
detrimental effect on the photocrosslinkable methacrylate/methacrylamide groups, and so was
chosen for more detailed examination. In biological analyses, we found that EtO treatment
successfully eradicated a bacterial challenge of E.Coli, caused no decrease in viability of
human mesenchyman stem cells (hMSCs), and had no effect on their rate of proliferation.
Finally, we found that EtO-treated hydrogels supported encapsulated hMSCs to differentiate
towards the chondrogenic lineage, and to produce new cartilage matrix. Our results bring to
light various effects that sterilisation can have on bio-inks, as well as highlighting EtO
sterilisation as a method which minimises degradation of properties, while still promoting
biological function.
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1

Introduction

Reliable and effective sterilisation of hydrogel based bio-inks is paramount for translation of
3D bioprinting to clinical practice. Efficient sterilisation is crucial to minimize the incidence
of implant-related infections, which are a major concern in health care.1 Demonstration of
compliance with sterility standards (such as ISO 11737: Sterilisation of medical devices) may
also be required by regulators. However the logistical requirements for sterilising materials
for biofabrication and bioprinting are different than those for implants. While medical devices
or biomaterial scaffolds can typically be sterilised in a terminal stage, immediately prior to
implantation or packaging, 2,3 bio-inks for live cell printing must be sterilised much earlier: i.e.
at least prior to the encapsulation of cells. This necessitates a fresh examination of the
sterilisation workflow in the context of biofabrication.
Despite the importance of sterilisation, its effects on the properties of hydrogels remains understudied,1 and most particularly in the bioprinting space. To our knowledge, there have been no
studies to date which address the sterilisation of bio-inks for 3D bioprinting. This is surprising
considering the recent explosion in research on bio-ink development. The extant hydrogel
sterilisation literature is not sufficient because it typically does not address certain properties
of key importance for bio-inks, such as rheology, printability and the mechanical properties
following crosslinking. On top of this, the past decade has seen particular classes of
photocrosslinkable bio-ink materials, such as methacrylate/methacrylamide functionalised
hydrogels, rise in prominence in the field of biofabrication. Again, we have not uncovered any
studies which address the effect of sterilisation methods on this emerging family of materials.

Sterilisation will unavoidably cause some changes to materials. The purpose of sterilisation is
to remove or inactivate microbial contaminants that may be present, typically by denaturing
proteins, disrupting cellular membranes or enzyme systems, or destroying their nucleic acid
bases. Each of these approaches has the potential to alter the biomaterial being sterilised, which
may compromise performance. Hydrogels and soft biomaterials are especially susceptible to
such collateral damage, being highly sensitive to common sterilising agents, such as heat and
radiation.1 Sterilisation can lead to degradation and/or decomposition of materials,
discoloration, embrittlement, odor generation, and can promote further crosslinking or induce
toxic effects.1 There is thus a need to determine sterilisation processes which minimises
hydrogel deterioration, while still guaranteeing sterility. Furthermore, any unavoidable effects
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of sterilisation on relevant properties should be documented, and taken into account during the
bio-ink formulation stage.
The critical characteristics of bio-inks encompass rheological and mechanical properties,
biocompatibility, presence of cell-adhesion sites and degradability among others, and all of
these properties must be retained following sterilisation. For example, to maintain printability,
bio-inks require rheological properties such as a high yield stress, high viscosity and strong
shear thinning behaviour4. Some hydrogels, such as gelatin and hyaluronic acid, are commonly
added to bio-inks to modify rheological properties to favour printing.5–9 Sterilisation should
not overly disrupt these critical rheological characteristics.
Besides having suitable rheological properties, bio-inks are typically designed to form ‘bioscaffold’ environments for cell encapsulation in 3D. To maintain shape fidelity, bio-scaffolds
must be structurally stable under physiological conditions. Common strategies to achieve this
include the formation of crosslinked hydrogel networks, using photoinduced free-radical
polymerization10–12 and enzymatic-based crosslinking13,14. In recent years, the strategy to
functionalise naturally derived hydrogels with photocrosslinkable groups has come to the fore,
producing materials such as gelatin methacryoyl (GelMA)10,15–20 and hyaluronic acid
methacryloyl (HAMA).8,16,21–24 These materials have potential applications across a wide
range of tissues, depending on how their mechanical properties are tailored.8,12,20 Thus,
sterilisation processes applied to these materials must also be screened for their effects on
hydrogel crosslinking.
Methods previously reported for sterilising bioink materials include UV irradiation25–28,
autoclaving6,29,30 (especially for gelatin), repeated heating,5 and filter-sterilisation15,17
(especially for GelMA). Ethylene oxide (EtO) gas31,32 and gamma-irradiation21 have also been
used, although more rarely. Most often, the sterilisation method is not reported.
In this work, we examined the effects of various sterilisation methods on four of the most
common hydrogels used to formulate bio-inks for 3D bioprinting: gelatin,5–7,9 GelMA,10,15–20
hyaluronic acid (HA),8,21 and HAMA.16,22–24 We decided to characterise each of these
hydrogels individually since different combinations of these materials can be used to formulate
any number of bio-inks targeting particular tissues. The paper is organised broadly in two
sections. The first half is an exploration of the effect of various sterilisation methods on the
physical properties (rheological and mechanical) of these four bio-ink components. Here we
evaluated the effects of both autoclaving and EtO-treatment for all four hydrogels, as well as
sterile filtration for GelMA (the other materials being unable to be filtered). Through these
analyses, ethylene oxide treatment (EtO) emerged as the least destructive sterilisation method
4

in terms of the physical and chemical properties tested, and so was chosen for more detailed
examination. The second half of the paper focuses on biological characterisation of EtOsterilised materials. After assessing the efficacy of EtO-treatment in eradicating a bacterial
challenge, we assayed the behaviour of human mesenchymal stem cells (hMSCs) encapsulated
within EtO-treated materials in terms of their viability, proliferation and differentiation.
Our results bring to light the various effects that sterilisation can have on bio-inks, as well as
highlighting EtO treatment as a method which minimises degradation of properties, while still
promoting biological function.
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Methods

2.1 Materials
Gelatin type A from porcine skin (~300 Bloom) was sourced from PB Leiner and hyaluronic
acid sodium salt from Streptococcus equi (mol wt. 1.6~2.0 x 106 Da) was obtained from
Boading Faithful Industries Co. Ltd. Gelatin-methacryloyl (GelMA) and hyaluronic acid
methacrylate (HAMA) were synthesized as described previously.24 The degree of
functionalization for GelMA (70%) and HAMA (20%±3%) was quantified by 1H-NMR in
D2O.33 The freeze-dried products were stored at -80 °C prior to use.

2.2

Materials preparation and sterilisation
2.2.1

Autoclave sterilisation

The materials were dissolved to a final concentration of 100 mg ml−1 (GelMA or gelatin) and
40 mg ml−1 (HA or HAMA) in sterile PBS (Sigma-Aldrich). Autoclaving was performed in a
Tomy Autoclave SX 500E for 20 minutes at 121 C.
2.2.2

EtO sterilisation

All materials were EtO sterilised in powder form. Powders were aliqoted into 50 ml centrifuge
tubes with vented caps, 0.2 µm pore size (Corning 50 ml mini bioreactor, Sigma-Aldrich, cat.
no. CLS431720). Aliquots were held in a humid environment at room temperature for 4hrs to
ensure any bacterial spores were not in a dessicated state. (Some bacterial spores can become
resistant to ethylene oxide sterilisation if dessicated).34 Alternatively, a drop of water can be
added to each tube to hydrate lyophlized hydrogels.
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EtO sterilisation was performed in an Anprolene EtO sterilizer (Anderson Sterilizers Inc.,
USA) at room temperature (23C) for a 12-hour cycle, followed by a further 12-hour purge to
flush the materials/plasticware of residual EtO. Materials were prepared according to the
manufacturer's instructions using an Anprolene ampoule, plastic liner bag and sterilizer
container. The Anprolene system is designed to allow diffusion of the EtO gas at a rate slow
enough to sterilize the contents. Each ampoule releases approximately 3800 mg EtO at room
temperature and atmospheric pressure, resulting in a minimum peak concentration within the
liner bag of 500mg/1000cm3. For consistent results it is important to load the sterilizer with
similar quantities of plasticware per cycle, since plastics absorb EtO during the cycle and
reduce the effective concentration. An EtO dosimeter chemical indicator (Anderson), placed
inside a vessel/package identical to those containing hydrogel, was used to confirm adequate
and consistent dosing of EtO for each cycle.
2.2.3

Filter sterilisation

GelMA was dissolved in MilliQ water at a concentration of 1.5% w/v GelMA, and filtered at
37°C in a class II biological safety cabinet using sterile 0.22-µm syringe filter units with a
polyethersulfone (PES) membrane. PVDF and glass membranes were also trialled, but these
could filter very little material before clogging. Filtered GelMA solutions were freeze-dried
(Martin Christ Alpha 1-2 LDplus) in pre-weighed tubes equipped with vent caps (Mini
Bioreactor Centrifuge Tube, Corning) for 4 days, or until the mass tubes had stabilised, then
stored in weighed aliqots in closed vessels at -80°C until needed.
2.3 Rheology
All rheology experiments were performed on a Physica MCR 302 Rheometer (Anton Paar) in
a cone-plate geometry (15 mm diameter with a cone angle of 1, and a truncation of 31 m) at
room temperature (23 °C). For flow experiments, the shear rate was ramped up from 0.001 to
100 s-1 over 200s. The yield stress was measured using the viscosity maximum method, i.e. the
stress at maximum viscosity.
2.4 In-situ photorheology
In-situ photorheology experiments were performed as previously described.12 Briefly,
oscillatory measurements were performed at 1% strain and an angular frequency of 10 rad s-1.
For in situ UV curing, 365nm light from the UV light source (Omnicure LX400+, Lumen
Dynamix LDGI) was used to illuminate the underside of the sample through a quartz crystal
stage. The UV intensity (100 mW/cm2) was measured at the sample using a UV meter
(Omnicure) before each experiment.
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2.5 Gel permeation chromatography (GPC)
All GPC analysis was performed on Shimadzu, LC-20 system comprising an isocratic pump,
an autosampler with variable injection volume, and a refractive index detector using two
columns connected in series. The first column was an ultrahydrogel 500, 10µm, 7.8x300mm,
mol.wt. range 10K-400K from Waters (part no. WAT011530) and second column was
ultrhydrogel 250, 6 µm, 7.8x300mm, mol.wt. range 1K- 80K from Waters (part no.
WAT011525). Phosphate buffer with 0.2M NaCl and 0.5% sodium docecyl sulphate was used
as mobile phase and the pH was 5.5. A flow rate of 0.6 mL/min was maintained. Temperature
of the column was kept at 35 oC. The concentration of GelMA samples for injection was 5mg/
2ml and injection volume was 100 µL. n=1 measurement for each GelMA sample. Poly
(styrene sulphonate) sodium salt standards (6K, 17K, 30K, 74K, 200K, 400K) were used for
the calibration curve.

2.6 Enzymatic crosslinking and mechanical testing
Microbial transglutaminase (TG) powder (Activa, Melbourne Food Depot) was dissolved in
DPBS, filter sterilized and added to gelatin solutions to make a final concentration of 10%
gelatin w/v and 2% TG. After thorough mixing, this solution was extruded into PDMS moulds,
covered with glass coverslips achieve flat surfaces, and incubated in a humidified environment
for 24hr to allow enzymatic crosslinking to reach completion. After crosslinking, samples were
swelled overnight in DPBS before mechanical testing. Compression tests were performed at
room temperature using a TA Electroforce 5500 mechanical loading device (TA Instruments,
USA) fitted with a 250 g load cell. The cross-sectional area of the sample was measured by
imaging with a steromicroscope (LEICA MZ6) before the test. The sample was compressed
between two stainless steel platens in an unconfined setting, and kept hydrated with a drop of
PBS solution. The displacement of the upper plate was controlled by a ramp function, at a rate
of 0.01 mm s−1, until a total displacement of 25% of the sample height was reached. The point
of inflection of the loading curve was used to measure the sample height.17 Load and
displacement measurements were converted into stress (σ) and strain (ε) data using the crosssectional area and height. The compressive modulus was then computed using the slope of the
stress-strain curve between a strain of 0.1 and 0.15 strain, according to literature protocols.17
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2.7 Extrusion-based 3D printing
Extrusion printing was performed on an Inkredible 3D bioprinter (CELLINK AB, Sweden)
running custom g-code and using a tapered nozzle with inner diameter 0.20 mm (Nordsen
EFD). Extrusion pressure and write speed were optimized at 125 kPa and 300 mm/min
respectively and the layer height was 0.2 mm.
2.8

Sterility testing: Bacterial challenge

An E. coli strain (Stbl3) transformed with a plasmid containing the gene for resistance to
ampicillin (VectorBuilder, Shenandoah, TX 77384, USA ) was cultured overnight (O/N) in
Lennox Luria Broth (LB, Sigma Aldrich) with ampicillin (100 μg/ml, Sigma- Aldrich). The
infection of materials was carried out by dropping 100 μl of O/N culture in 10 ml LB with an
O.D. 1.0 at 600 nm onto 0.1 g of freeze-dried hydrogels inside a 50 ml sterile tube (Corning).
Considering an OD600 of 1.0 corresponds to ~8 x 108 cells/ml, each hydrogel was infected with
approx. 8x107 bacteria. Four materials were analysed: Gelatin, GelMA, HA, HAMA under four
conditions: (i) non-infected, non-EtO-treated; (ii) non-infected, EtO-treated; (iii) infected nonEtO-treated; (iv) infected, EtO-treated. The non-infected groups were treated with 100 μl of
LB + ampicillin. At the end of the EtO cycle all the groups were resuspended in 20 ml LB +
ampicillin. Bacterial growth was carried out for a subsequent 24 h at 37°C. 100 μl of a 1:10
dilution in LB + ampicillin of each sample was transferred to a 96 well plate. O.D. 600nm was
read every hour for 6 hours on a CLARIOstar plate reader (BMG Labtech, Ortenberg,
Germany). Pure LB + ampicillin was used as the reference.

2.9 Cell viability
2D assay: adipose derived human adipose-derived mesenchymal stem cells (hADSCs) were
isolated and cultured as previously described,35 seeded into multiwell plates at a density of
4000/cm2 and cultured for 24 h in proliferation medium. The medium was then removed and
replaced by medium containing 10% w/v of either untreated GelMA or EtO-treated GelMA.
The GelMA used for this experiment was EtO-treated one day before being exposed to the
cells, representing the situation of high risk for residual EtO content. The hADSCs were
cultured for a further 24 h before being assessed for metabolic activity using a CellTiter Blue
(Promega, Wisconsin, United States) assay, following manufacturer’s instructions with a 4 h
incubation time at 37°C. CellTiter-Blue solution was frozen at -80°C until required. For the
quantitative measurement, vials of the resultant CellTiter-Blue solution were thawed and 100
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μl duplicates were placed into a 96-well PE OptiPlate and read using 550-15/600-20
emission/excitation fluorescence wavelengths in a CLARIOstar plate reader (BMG Labtech,
Ortenberg, Germany). Cell numbers were calculated based upon a calibration curve of known
cell densities

3D assay: hADSCs were encapsulated in 10% GelMA (EtO-treated, autoclaved or filtered)
containing 0.1% w/v lithium-acylphosphinate (Tokyo Chemical Industry Co.) and photocrosslinked with 10 s exposure of 365 nm light at 700 mW/cm2 as previously described.35 The
cells were incubated for 7 d in proliferation medium. Metabolic activity was assessed through
a CellTiter-Blue assay at days 1, 3, and 7. The samples were incubated for 4 h at 37°C before
the media sample was removed. 500 μL of dimethyl sulfoxide (DMSO) (MP Biomedicals,
California, United States) was added to the scaffolds and incubated for a further 1 h to retrieve
the metabolized resorufin trapped in the scaffold. After the DMSO step, the CellTiter-Blue
solution was frozen at -80°C until reading. For the quantitative measurement, vials of the
resultant CellTiter-Blue solution were thawed and 100 μL duplicates were placed into a 96well PE OptiPlate and read using 550-15/600-20 emission/excitation fluorescence wavelengths
in a CLARIOstar plate reader (BMG Labtech, Ortenberg, Germany).

2.10 Chondrogenesis
hADSCs were sourced from the infrapatellar fat pad of human donors as previously
described.35 Chondrogenesis of hADSCs embedded in 5% w/v gelatin, 5% w/v GelMA and
0.5% w/v HA + LAP 0.1% and photo-cured at 365 nm at 700 mW/cm2 for 10 s with a cell
density of 5x106 cells/ml, was induced by culturing them in a chondrogenic medium consisting
of high-glucose DMEM (Lonza), 100 Uml−1 penicillin and 100 μg.ml−1 of streptomycin
(Gibco), Glutamax (Gibco), and 15 mM HEPES (Gibco), 1% insulin-transferring-selenium
(Sigma- Aldrich), 100 nM dexamethasone (Sigma-Aldrich), 50 mgml−1 ascorbate-2-phosphate
(Sigma-Aldrich), 10 ngml−1 TGFβ3 (Peprotech), and 10 ng ml−1 BMP6 (R&DSystems) as
previously described.35 Media was changed twice weekly. The chondrogenic medium was
freshly prepared before changing the media.
2.11 Quantification of glycosaminoglycan (GAG) and DNA
To quantify GAG content, 0.5 mL Papain Extraction Reagent was added to each sample and
incubated at 60˚C for 3 hours with vortexing every hour, followed by centrifuge at 1 x105 G
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for 10 mins at room temperature. Supernatant was collected and 100 μL of which was further
mixed with 500 μL DMMB reagent by vortex. 100 μL of the mixture was added into 96-well
plate and the absorbance were read by ClarioStar microplate reader. Based on a calibrated
standard curve of the standard solution of chondroitin-sulfate, the content of GAG was then
determined by the ratio of absorbance read at 525 nm and 595 nm.
DNA content was measured by using the same digested extract with Quant-iT PicoGreen
dsDNA Reagents Kit. A standard curve was prepared with Lambda DNA in the Kit. 100 μL of
Papain extraction was mixed with 100 μL PicoGreen, and 100 μL of the mixture was added
into ultravision 96-well plate. After incubating for 5 minutes at room temperature, the
fluorescence was read using a plate reader set at PicoGreen with Ex 483-15 nm and Em 53030 nm at 4.6 focal plate height, Gain 1500.

2.12 RNA extraction, Reverse transcription and qPCR analysis
Total RNA isolation and RT-qPCR analysis was performed as previous reported (Onofrillo et
al., 2018). Briefly, total RNA of hMSCs were extracted using TriZOL (Thermo Scientific)
reagent and Direct-Zol RNA extraction Kit (Zymo Research),Following the manufacturer’s
protocols. Reverse transcription (RT) of 500 ng of RNA for each sample was performed using
High Capacity Reverse Transcription Kit (Thermo Scientific). The relative amounts of
COL2A1, COL1A2, SOX9, and GAPDH RNAs were evaluated with TaqMan gene expression
assay (Applied Biosystems, Foster City, CA, USA). RT-qPCR was performed on a
QuantStudio6 Flex Real-Time PCR System (ThermoFisher Scientific) and relative
quantification was calculated with the 2E−ΔΔCT method.
2.13 Confocal Microscopy
Immunostaining was performed on the whole scaffold as previously described.24,35 Briefly,
cell-laden samples were fixed using 4% paraformaldehyde for 30 min at room temperature.
After being washed three times in PBS and permeabilized in PBT (0.1% Triton in PBS) for 60
min,antigen retrieval was performed by adding 1mg/mL hyaluronidase diluted in PBS and
incubating 30 min at room temperature. After three washes of 5 min each in PBS, samples were
dropped into blocking solution (10% goat serum diluted in PBT) for 60 min at room
temperature and then incubated overnight at 4 °C with mouse anti-human collagen II, diluted
1:250 in blocking solution. The next day, samples were washed five times for 10 min each and
secondary antibody (anti-mouse IgG Alexa Fluor-647) diluted 1:100 in blocking solution was
added and incubated for 2 h at room temperature. After five washes (5 mins each in PBS) ,
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samples were incubated with active labeling solution (Phall-FITC) 1:500 diluted in PBT and
incubate 2 h at room temperature. After five washes (5 mins each in PBS) , actin was labelled
with Texas Red-X Phalloidin 1:100 diluted in PBS for 60 min at room temperature and nuclei
were stained by incubation with 5 μg/mL DAPI diluted in PBSfor extra 60 min at room
temperature. Samples were kept at 4˚C until confocal imaging was performed on a NikonA1R
confocal microscope using a Nikon 20X Objective PLAN APO AirDIC NA 0.75 WD 1000
and z-intensity correction during the scan. Z-stacks of 2.5 um each were processed for 3D
rendering (volume view) using NIS-Elements software (Nikon, Amsterdam, Netherlands) and
the Alpha-blending algorithm plug in.
2.14 Statistical Analyses
Statistical analyses were performed using Prism 7 (Graphpad Software Inc.). To test for
statistical differences between multiple groups, one way ANalysis Of VAriance (ANOVA) was
performed using Tukey’s post-hoc test. Direct comparisons between two groups were
performed using an unpaired t-test with Welch’s correction. By convention statistical
significance was considered to be reached for p<0.05.

3

Results and Discussion

3.1 Initial screening of sterilisation methods
In preliminary work, we explored a range of sterilisation techniques for methacrylated
hydrogels. Ethanol sterilisation was discarded because it did not result in a sterile material.
Gamma irradiation was discarded as it resulted in noticeable colour change of the
methacrylated materials (see supplementary information). Filtration was only practicable for
GelMA, and not for gelatin, HA, or HAMA due to clogging of the 0.22um syringe filters. After
this screening step, we chose to proceed with further examination of autoclaving and EtO
treatments for all four materials, as well as filtration for GelMA only.
Autoclaving uses moist heat at high pressure to destroy microorganisms by the irreversible
coagulation and denaturation of enzymes and structural proteins. However, besides eradicating
microbes, the high pressure and temperature can severely degrade the materials being sterilised.
The filtration method of sterilisation excludes organisms from a material based upon size.
Filtration through a membrane with a pore size of 0.2 µm will remove biological contaminants,
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including bacteria, mould and yeast, with sterile 0.22 µm filters being the industry standard.36
Nevertheless some species of bacteria have been shown to be flexible enough to pass through
0.22 µm filters.37
At room temperature and pressure, ethyelene oxide is a highly reactive gas which is lethal to
mycobacteria, vegetative bacteria (gram-negative and gram-positive), bacterial spores, fungal
spores, enveloped and naked viruses and prions.38 The mechanism of sterilisation is alkylation
of sulfhydryl, amino, carboxyl, and hydroxyl groups, which damages proteins and nucleic
acids.39 Inactivation of bacterial endotoxin by EtO has also been reported.40
3.2 Effect of sterilisation methods on the rheology of bio-ink materials.
Following the screening step, the chosen sterilisation methods were assessed for their impact
on rheological properties of the four bio-ink materials. Formulating a printable bio-ink requires
careful consideration of many rheological properties including viscosity,16,41 shear-thinning
behavior,16,42 yield stress,25,42 viscoelasticity,7 shear recovery42 etc. We chose to quantify the
yield stress and the viscosity at a particular shear rate (1 s -1) as representative rheological
properties with which to monitor relative changes caused by sterilisation. (The viscosity at zero
shear-rate is also reported in the supporting information. Within each data set these 0 s-1 data
exhibit very similar trends to the viscosity at 1 s-1 for all materials). Rheological properties
were assessed for untreated materials, autoclaved materials and EtO-treated materials for all
four hydrogels (gelatin at 10% w/v, GelMA at 10% w/v, HA at 4% w/vand HAMA at 4% w/v),
as well as the additional filtered group for GelMA.
Figure 1 (a-c) shows the effects of sterilisation on the rheological properties of gelatin
solutions. The shear-ramp data presented in Figure 1 (a) describes similar rheological behavior
for the untreated and EtO-treated gelatin, with both materials exhibiting increasing viscosity at
low shear rates, reaching a peak of ~5000 Pa.s, at which point the yield stress was reached and
shear-thinning behavior ensued. The viscosity of autoclaved gelatin was dramatically lower,
generally < 10 Pa.s at all shear rates, and appears only as a baseline viscosity on the scale of
the plot. The quantitative analysis presented in Figure 1 (b-c) supports these two clear effects:
(i) EtO treatment did not result in measurable changes in either yield stress or viscosity, with
both properties showing no significant differences relative to the untreated materials. (ii)
Autoclaving caused a dramatic reduction in both yield stress and viscosity, with both properties
showing significant differences (p<0.01 and p<0.0001 respectively) relative to the untreated
group. This effect of autoclaving is unsurprising since gelatin is known to degrade at elevated
temperatures though hydrolysis of peptide bonds and internal cross-links.43
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Figure 1 (d-f) shows the effects of sterilisation on the rheological properties of GelMA
solutions. For autoclaving and EtO treatment, the results correlate with the effects obtained for
the analysis of gelatin. Again, EtO treatment resulted in a similar shear-ramp profile to the
untreated group, with similar (if slightly increased) yield stress values and a similar viscosity.
Once again, autoclaving produced a dramatic reduction in both properties.

Figure 1: Effect of sterilisation on the rheological properties of gelatin 10% w/v and GelMA 10% w/v solutions.
(a) Viscosity as a function of shear rate for gelatin materials. Both untreated and EtO-treated gelatin solutions
showed increasing viscosity up to a peak of 4000-5000 Pa.s, with shear-thinning behaviour at higher shear-rates.
The autoclaved gelatin, by contrast, had an extremely low viscosity (<10 Pa.s) at all shear-rates. (b) Yield stress
for gelatin materials. Untreated and EtO-treated gelatin solutions exhibited a yield stress greater than 1000 Pa,
with no significant difference between them. Autoclaved gelatin showed a dramatically lower yield stress of below
0.5 Pa. (c) Viscosity at a shear-rate of 1/s for gelatin solutions. Untreated and EtO-treated gelatin solutions had
similar viscosities of 449 ± 15 Pa.s and 417 ± 63 Pa.s repectively, with no statistical significance between them.
The viscosity of autoclaved gelatin was dramatically lower, at 0.11 ± 0.17 Pa.s. (d) Viscosity as a function of
shear rate for GelMA materials. The viscosities of GelMA solutions were about an order of magnitude lower than
for the gelatin solutions. Both untreated and EtO-treated GelMA solutions showed an increasing viscosity up to
a peak of 500-700 Pa.s, with shear-thinning behaviour at increasing shear-rates thereafter. Autoclaved GelMA
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exhibited an extremely low viscosity (<1 Pa.s) at all shear-rates. (e) Yield stress for GelMA materials. Untreated
GelMA solutions exhibited a yield stress of 155 ± 17 Pa Pa, and EtO-treated GelMA a yield stress of 225 ± 39
Pa, with a small statistical significance between them (p=0.02). Filtered GelMA had a yield stress of 106 ± 13
Pa, with no significant difference w.r.t. the untreated material. Autoclaved GelMA showed a very low yield stress
of just 0.027 ± 0.006 Pa. (f) Viscosity at a shear-rate of 1/s for GelMA solutions. Untreated and EtO-treated
GelMA solutions had viscosities of 172 ± 6 Pa.s and 172 ± 14 Pa.s respectively, with no statistical significance
between them. The viscosity of filtered GelMA was 125 ± 7 Pa.s, which was significantly different compared to
both the untreated (p=0.0007) and EtO treated (p=0.0006) materials. The viscosity of autoclaved GelMA was
dramatically lower than all other groups, at less than 0.03 Pa.s.
Notes: In graphs (a) and (d), black, upward-pointing triangles indicate untreated materials, red squares indicate
autoclaved materials, blue circles indicate EtO-treated materials and green, downward pointing triangles
indicate filtered materials. n=3 or greater for all groups. * p<0.05, ** p<0.01, ***p<0.001, **** p<0.0001.
Error bar represent standard deviation.

Interestingly, the rheological properties of the filtered GelMA group were reduced with respect
to those of the untreated control. This could not be due to loss of mass during filtering, since
all material was freeze-dried and weighed after the filtering step, before being re-dissolved at
10% w/v. We hypothesized that the filtration was preferentially removing higher molecular
weight molecules from the GelMA materials, which would reduce overall viscosity. To resolve
the question, and to obtain an indication of the effects of the different sterilisation methods at
the molecular scale, we performed gel permeation chromatography (GPC) and nuclear
magnetic resonance (NMR) spectroscopyon the four GelMA samples (
Table 1).
NMR spectroscopy revealed that the degree of functionalisation was similar for all materials,
indicating that the methacryloyl groups were not directly impacted by any of the sterilisation
techniques. The NMR spectra were similar in all cases, indicating minimal chemical
modification of GelMA by any treatment (see supporting information). From the GPC analysis,
untreated GelMA was found to be composed of highly polydisperse macromolecules with a
number average molecular weight (Mn) of ~41 kDa, a weight averaged molecular weight (Mw)
of ~179 kDa and a dispersity (Mw/Mn) of 4.3. For filtered GelMA, the Mn stayed stable at 40
kDa, while the Mw decreased to ~146 kDa. This indicates that smaller macromolecules had
survived the filtering process, while larger macromolecules had been removed (thus explaining
the reduction in viscosity observed for filtered GelMA). Autoclaving caused significant
shortening (i.e. a ~50% reduction) of the macromolecules of GelMA, yielding Mn of ~23 kDa
and Mw of ~83.5 kDa. This autoclave-induced degradation of GelMA is to be expected since
high temperatures cause gelatin to degrade through hydrolysis of peptide bonds and internal
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cross-links.43 EtO-treated GelMA had a Mn of ~32 kDa and Mw of ~161 kDa, indicating some
reduction of larger molecular weight components, with a concomitant increase in the number
of small macro molecules. 3, In a study of the reaction of ethylene oxide with gelatin, Gantar
et al. found that the prevailing reaction was addition of EtO onto the free -NH2 groups on the
amino acids with basic side chains at neutral pH (i.e. lysine, arginine, aspartine) only.44 Such a
reaction would have a minimal effect on molecular weight (though in our GelMA materials,
about 70% of these groups are functionalised with methacrylamide). Thus we suggest that the
slight decrease in molecular weight found in EtO treated GelMA may be due to hydrolytic
degradation splitting some of the GelMA chains. Others have observed hydrolytic degradation
of gelatin incubated at 30C for 24 hours, conditions not dissimilar from our EtO sterilisation
conditions (25C over 24 hours). Altogether, EtO treatment had the smallest effect on
molecular weight of GelMA, followed by filtering, with autoclaving the most detrimental.
Table 1: Gel permeation chromatography and NMR analysis of GelMA materials.

Untreated

Filtered

Autoclaved

EtO

Mn

41390

40655

23287

32431

Mw

178896

146260

83521

161300

4.32

3.60

3.59

4.97

69.6%

69.5%

69.5%

69.6%

Dispersity
Degree of
functionalisation

Figure 2 (a-c) shows the effects of sterilisation on the rheological properties of HA solutions.
EtO-treated HA showed similar rheological behavior to untreated HA under shear ramp
conditions, but with a slightly lower viscosity at all shear rates. The viscosity of autoclaved
HA was less than half that of either untreated or EtO-treated HA at low shear-rates. Due to
strong shear thinning behavior, all three HA groups approached similar viscosities at very high
shear rates (10-100 s-1). The yield stress value for EtO-treated HA (~15 Pa) was slightly lower
than that of untreated HA (~18 Pa), but this difference was not statistically significant.
However, the yield stress of autoclaved HA (~7 Pa) was far lower than either group, and these
differences were significant (p>0.01 relative to EtO-treated and p<0.001 relative to the
autoclaved group). The viscosity at 1 s-1 of the untreated HA was higher than that of either the
EtO or untreated groups, which were similar. However, EtO-treated HA had a significantly
higher zero-shear rate viscosity than autoclaved HA (see supporting information). This
disparity is explained by the strong shear-thinning behaviour of HA. At very low or zero shear
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rates, HA molecules are entangled in random orientations, producing viscosities which are
related to the HA chain length (with untreated > EtO treated > autoclaved). However as shear
rates approach 1 s-1, viscosity drops due to shear-induced alignment of the HA molecules, and
in this situation the viscosity is not as strongly affected by chain length (so the viscosities of
untreated, EtO treated and autoclaved HA are relatively similar).
Figure 2 (d-f) shows the effects of sterilisation on the rheological properties of HAMA
solutions. HAMA, in general, exhibited a much lower viscosity than the HA. In the shear-ramp
plot, the viscosity of untreated HAMA was the highest at all shear-rates, followed by EtO
treatment and then autoclaving. HAMA did not exhibit yield point behavior, and so the yield
stress values for all HAMA groups were very low, and similar for all groups (~2 Pa). The
viscosity at 1 s-1 of the untreated HAMA was the highest (~20 Pa.s) followed by EtO treatment
(~12 Pa.s) and finally the autoclaved HAMA group (~8 Pa.s). The differences in viscosity
between all groups were highly significant (p<0.0001).

Figure 2: Effects of sterilisation on the rheological properties of HA 4% w/v and HAMA 4% w/v solutions. (a)
Viscosity as a function of shear rate for HA materials. Untreated and EtO-treated HA solutions showed increasing
viscosities at low shear rates up to peaks of 1313 ± 121 Pa.s and 1030 ± 73 Pa.s respectively whereas autoclaved
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HA had a peak viscosity of just 425 ± 73 Pa.s, with shear-thinning behaviour at increasing shear-rates thereafter.
(b) Yield stress for HA materials. Untreated HA solutions exhibited the highest yield stress (18.6 ± 1.6 Pa),
followed by EtO-treated HA (15.0 ± 2.1 Pa), with no significant difference between them. Autoclaved HA had
much lower yield stress (7.4 ± 1.4 Pa), which is significantly different compared to both other groups (p=0.0054
vs EtO-treated and p=0.0007 vs untreated). (c) Viscosity at a shear-rate of 1/s for HA solutions. Untreated HA
exhibied the highest viscosity (143 ± 20 Pa.s), which was significantly higher than the other groups. EtO-treated
(105 ± 5 Pa) and autoclave-treated HA (97 ± 15 Pa) exhibited similar viscosities. (d) Viscosity as a function of
shear rate for HAMA materials. The viscosities of HAMA solutions were dramatically lower than for HA. All
materials showed a steady or slightly increasing viscosity at low shear rates, with shear thinning onset at a rate
of ~1/s. Untreated HAMA solutions were the most viscous, EtO-treated HAMA exhibited intermediate viscosity,
and autoclaved HAMA had the lowest viscosity. (e) Yield stress for HAMA materials. HAMA solutions did not
show yield point behaviour (as shown by the lack of a ‘yield viscosity’ peak in figure (d). All HAMA solutions thus
exhibited a very low yield stresses of 2 Pa, with no statistical signifance between any of the groups. (f) Viscosity
at a shear-rate of 1/s for HAMA solutions. Untreated HAMA, EtO-treated HAMA and autoclaved HAMA had
viscosities of 20.3 ± 0.5 Pa.s, 12 ± 0.3 Pa.s and 8.2 ± 0.1 Pa.s respectively, with significant differences (p<0.0001)
between all groups.
Notes: In graphs A and D, black, upward-pointing triangles indicate untreated materials, red squares indicate
autoclaved materials, and blue circles indicate EtO-treated materials. n=3 or greater for all groups in all
experiments. * p<0.05, ** p<0.01, p<0.001, ***** p<0.0001. Error bars represent standard deviation.

Our results show that autoclaving caused a large reduction in the rheological properties of the
hyaluronic acid-based materials, a finding that agrees with literature reports.45,46 This reduction
in viscosity is likely due to splitting of the HA molecule into shorter chains. HA is a large, rigid
polysaccharide, but its molecular backbone can be quite easily depolymerised by splitting the
(C-O-C) glycosidic bonds by heating, oxidation, and other effects.46 For example, Reháková
et al. found the average molecular weight of HA decreased from 1.4 x 106 to 1.18 x 106 when
heated to 90ºC for one hour.46 Meanwhile Bothner et al., saw a reduction in both limiting
viscosity number and molecular weight as a function of autoclaving time at 128ºC, with the
kinetics of heat degradation in agreement with random scission of the HA chain.45 In contrast
to the gelatin-based materials, the rheological properties of hyaluronic acid materials were also
reduced by the EtO treatment. It is possible the glycosidic bonds are also susceptible to
cleavage during EtO sterilisation, either due to the action of the EtO itself or by other species
generated in reactions of EtO with water. While a detailed descriptiong of the mechanism of
HA degradation is outside the scope of this study we note that, in neutral aqeous conditions,
the epoxide ring opening reaction which converts EtO to ethylene glycol is achieved through
hydrolysis with pathways for producing either H+ and OH- species.47 Hyaluronan has been
found to be particularly susceptible to cleavage by free radicals including both H+ and OH-.48
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For example, Kvam et al. found that hydroxy radicals caused a ten-fold decrease in number
averaged molecular weight of HA after one hour of exposure.49 Regardless, our results show
that EtO treatement caused much less reduction in rheological properties of both HA and
HAMA compared with autoclaving.
3.3

Effect of sterilisation methods on the crosslinking of bio-ink materials.

In this work, we investigated how various sterilisation methods affected the photocrosslinking
of GelMA and HAMA as well as the enzymatic crosslinking of gelatin by transglutaminase.
Figure 3 summarises these results. Neither filtration nor EtO treatment significantly affected
the photocrosslinking of GelMA, with both groups reaching similar final storage modulus
values as the untreated group. Autoclaved GelMA showed a significant decrease in mechanical
properties, resulting in a storage modulus of about half that of the other groups. These results
echo those seen in the rheological measurements of GelMA, where EtO and filtration both had
a minimal effect but autoclaving caused a dramatic reduction in viscosity.
The final storage modulus achieved by HAMA solutions was significantly impacted by both
EtO and autoclave treatment relative to the untreated group. While untreated HAMA reached
a final storage modulus of ~1500 Pa, the EtO-treated group reached ~1100 Pa and the
autoclaved group reached only ~600 Pa. These results also echo those seen in the measurements
of HAMA viscosity, where EtO caused some reduction in viscosity but not as much as
autoclaving.
Importantly, these results suggest that the photocrosslinkable groups of methacrylate and
methacrylamide are not being affected by the EtO treatment. In the case of GelMA, no change
in photocrosslinking rate or final modulus was observed following EtO treatment. This is as
expected considering EtO caused no reduction in the degree of functionalisation of GelMA and
only a relatively small reduction in molecular weight. The reduction in the final storage
modulus for EtO-treated HAMA are likely due to shortening of the HAMA chains, rather than
deactivation of the photocrosslinkable groups. We have not found any published reports which
discuss the effect of EtO on the photocrosslinking of methacrylated polymers. Several reports
do mention EtO being used for sterilisation of methacrylated hydrogels, without specific
investigation of its effect on the mechanical properties of the materials.21,32,50

Sterilisation by both EtO and autoclaving strategies caused small decreases in the mechanical
properties of enzymatically crosslinked gelatin, however these differences were not significant.
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The compressive modulus of TG-crosslinked gelatin solutions was ~28000 Pa for the untreated
gelatin, ~24000 Pa for the EtO-treated gelatin and ~20000 Pa for the autoclaved gelatin. The
minimal decrease in TGase crosslinking suggest neither the EtO or the autoclaving have a
major impact on the structure to these groups. Transglutaminase crosslinks lysine and
glutamine groups present on the gelatin. Previous work has reported that EtO reacts with lysine
through hydroxyethylation of one or both of its primary amino groups, although these reactions
are strongly dependent on the EtO exposure conditions and on the particular protein being
assayed.51 Autoclaving has also been shown to reduce the concentration of both lysine and
glutamine in casein proteins.52

Figure 3: Effect of sterilisation on the crosslinking of hydrogels. (a) Photocrosslinking of GelMA 10% w/v
solutions monitored using in-situ photo-rheology. Untreated, filtered and EtO-treated GelMA showed similar
photo-crosslinking profiles. Autoclaved GelMA 10% w/v solutions showed a similar rate of reaction, but with a
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storage modulus less than half that of the other groups. (b) Final storage modulus values of cross-linked GelMA
was in the range of 8000-1000 Pa for untreated, filtered and ETO-treated groups, with no statistical significance
between any of them. However, the final storage modulus of autoclaved GelMA decreased markedly to ~5000 Pa,
a highly significant decrease compared to untreated GelMA (p=0.0007). (c) Photo-crosslinking of HAMA 4% w/v
solutions monitored using in-situ photo-rheology. There was a clear difference in photo-crosslinking profiles,
with untreated HAMA producing the highest modulus, followed by EtO treatement and then autoclaving. The
rates of reaction were similar, with all materials reaching plateaus after about 40 s of light exposure. (d) The
final storage modulus of untreated, EtO-treated and autoclaved HAMA 4% were ~1500 Pa, ~1100 Pa and ~600
Pa respectively. There were highly significant differences between all three groups (p<0.0001). (e) Typical
stress-strain curves from compressive modulus measurements of gelatin 10% solutions crosslinked using
transglutaminase. (f) The compressive modulus of transglutaminase -crosslinked gelatin 10% solutions was
~28000 Pa for the untreated gelatin, ~24000 Pa for the EtO-treated gelatin and ~20000 Pa for the autoclaved
gelatin, however there were no statistically significant differencse between any of these groups. Error bars
represent standard deviation. n=3 or greater for all groups in all experiments.

3.4 The election of EtO as an effective sterilisation method
The results from all rheological and mechanical tests are summarized in Figure 4 below.
The most detrimental sterilisation strategy is autoclaving. Autoclaving caused a dramatic
reduction in viscosity for all four materials. It also caused a large decrease in storage modulus
for the photocrosslinked GelMA and HAMA, as well as a small (though non-significant)
decrease in the compressive modulus of enzymatically crosslinked gelatin.
Filtering caused some reduction in rheological properties of GelMA, but did not affect
photocrosslinking. Filtration also results in a significant loss of material: in our hands a ~13%
loss of material when manually filtered and a ~9% loss when filtered using a vacuum filtration
system. Although filtration is the most common form of sterilisation reported for GelMA,
challenges with scale-up, and its non-applicability to other, larger molecular weight materials
are limitations.
Our results suggest EtO treatment is the most promising method for sterilizing all four bio-ink
materials. EtO treatment seems especially suited for gelatin and GelMA, where it had minimal
effect on the rheological properties and crosslinking for both of these materials. EtO is more
detrimental to HA and HAMA, where it impacted negatively in terms of viscosity and (for
HAMA) photocrosslinking. The decreases on these properties were still significantly less than
those caused by autoclaving.
Besides these considerations of damage limitation during sterilisation, EtO treatment is also a
highly scalable process. For materials which are not strong absorbers of EtO, the capacity of
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EtO sterilizers is limited only by the volume of the chamber. This means that relatively large
quantities (>1kg) of biomaterials can be sterilized in one cycle of a typical benchtop unit.

Figure 4: Summary of rheology and crosslinking measurements. All rheological and mechanical data are presented
relative to each untreated group (normalised at 100%, with error bars presented as grey ellipsoids). Gelatin and
GelMA: In general, EtO treatment had little effect on the rheological and crosslinking properties of gelatin and
GelMA materials. Filtration reduced the rheological properties of GelMA, without affecting crosslinking.
Autoclaving dramatically reduced the rheological properies of both gelatin and GelMA, and also somewhat
reduced crosslinking strength. HA and HAMA: EtO treatment reduced the rheological properies of HA and
HAMA, although not as much as autoclaving. EtO treatment also reduced the final crosslinking modulus of
HAMA, but again the impact of autoclaving was more detrimental. Error bars represent standard deviation.

3.5

Bio-ink formulation

Having characterised the properties of the four hydrogels individually, we next performed an
experiment to illustrate how the choice of sterilision method can have a practical impact upon
the bio-ink formulation process. With a view to developing a bio-ink for cartilage regeneration
(as described in section 3.7 below) a base formulation of 5% GelMA and 0.5% HA was chosen.
Various concentrations of gelatin (from 1-10% w/v) were then incorporated, and the filamentforming ability of each formulation (a common screening test for printability)5,9,53 was assessed
at room temperature. (Both gelatin and HA are often used as bio-ink thickeners to increase
viscosity and/or gelation, and so achieve printable bio-inks.)5–9

21

We hypothesised that materials which retained higher rheological properties post-sterilisation
(i.e. EtO sterilised materials) would achieve printability at lower additive concentrations. In
this experiment we compared two groups of materials, one using materials which had been
EtO-treated and the other using materials sterilised my other means. Our rationale here was to
compare EtO treatment (of all materials) with the ‘best case’ or ‘default’ scenario chosen from
all other sterilisation methods: namely filtration for GelMA, and autoclaving for gelatin and
HA.
As shown in Figure 5 below, there is a stark difference in the printability between the two groups.
While the EtO-treated bio-inks could form a filament when just 5% w/v gelatin was added, the
filtered/autoclaved group did not form an extruded filament until 10% w/v gelatin was added.
Furthermore EtO-treated hydrogels generally produced much longer filaments than the
filtered/autoclaved group, and at lower concentrations of gelatin.9 In particular, the filament
length achieved by the filtered/autoclaved materials with 10% added gelatin was similar to that
achieved by the EtO-treated materials with half that amount (5%) of added gelatin. We also
confirmed the printability of the optimised EtO treated formulation (5% GelMA, 0.5% HA,
5% gelatin) by 3D printing various structures including the 6 mm tall, 30-layered log-pile
structure shown in Figure 5 (c-d).
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Figure 5: Bio-ink formulation using sterilised hydrogels. (a) Printability screening using the filament-formation
test. For the EtO-treated group, filament formation was achieved when the base formuation (5% w/v GelMA and
0.5% w/v HA) was supplemented with gelatin to a final concentration 5% w/v gelatin. The filtered/autoclaved
group required double this addition of gelatin (10% w/v) to form extruded filaments. (b) Measurement of the
length of the extruded filaments at break-point, as a function of added gelatin. EtO-treated hydrogels generally
produced much longer filaments than the filtered/autoclaved group, and at lower concentrations of added gelatin.
Error bars represent standard deviation. A minimum of n=3 filaments were measured for each condition. (c) 30
layer, 6 mm tall log-pile structure printed using a bio-ink formulated from EtO treated materials (GelMA 5%,
gelatin 5%, HA 0.5% w/v). (d) Photograph of the log-pile from (c) next to a mm-scale ruler to demonstrate its 6
mm height.. (e) Stereomicroscope image of a 3D printed pyramid (22-layers) using the same formulation. (f) )
Lines in a crosshatch pattern printed using the same EtO treated bio-ink. The printed lines are 268 +/- 34 μm
(measured from n=10 lines). (g) Stereomicroscope image of a 2.4 mm tall, 12 layer log-pile printed using the
EtO-treated bio-ink and dyed blue after printing to better visualise this highly transparent structure. Note: All
images in (c-g) were taken prior to any photocuring, showing the ability of the bio-ink to maintain shape fidelity
without relying on chemical crosslinking.

Considering these results, the remainder of this study focuses on EtO treatment only, and on
the biological characterisation of EtO-treated materials in particular. In our next step, we tested
the capability of EtO as a sterilisation method for gelatin, GelMA, HA and HAMA, through
issuing a bacterial challenge prior to treatment. We also assessed the viability proliferation and
differentiation of human MSCs exposed to EtO-treated materials.
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3.6

Contamination challenge for EtO-treated bio-inks

To test whether EtO treatment could sterilise contaminated bio-ink materials, we deliberately
infected samples of gelatin, GelMA, HA and HAMA with E. Coli prior to EtO treatment.
Besides the infected and EtO-treated samples, three relevant control groups were assayed for
each material, making for four experimental groups in total: (i) uninfected/untreated, (ii)
uninfected/EtO-treated, (iii) infected/untreated, (iv) infected/EtO-treated.
Following 24h incubation in LB, the relative abundance of bacteria in a 10 fold dilution of
solution was assayed by optical density at 600 nm. As shown in Figure 6 (a-d), the
concentration of bacteria were far higher in the infected/untreated groups than for any other
group for all four materials. To confirm that these bacteria were alive and proliferating, a
bacterial growth curve was then measured from aliquots of each solution, diluted 10-fold in
LB. As shown in Figure 6, the only group which permitted any bacterial growth was the
infected/untreated group. In contrast, the OD for the infected/EtO group tracked with the OD
for the uninfected controls. The strong contrast between the levels of bacterial growth can be
seen in Figure 6 (i-l), which shows photographs of each LB solution 72 hours after the day of
infection and treatment. While the infected/untreated solutions are densely clouded, the
infected/EtO solutions are clear, similar to the uninfected and untreated controls. From these
results, we conclude that EtO treatment effectively reduced the concentration of viable bacteria
to below detectable levels for all four materials.
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Figure 6: Sterilisation test for EtO treatment. Four conditions were tested for each material: (i) uninfected
untreated, (ii) uninfected EtO-treated,(iii) infected untreated, (iv) infected-EtO-treated. (A-D) Initial bacterial
growth in gelatin, GelMA, HA and HAMA respectively. Optical density reading at 600 nm following 24 h
incubation in LB . The OD reading for the infected/untreated group wers far higher than any of the other groups
for each material, and showed a statistically significant difference (p<0.0001) relative to the infected/EtO group
in each case. (E-H) Bacterial growth curves for gelatin, GelMA, HA and HAMA respectively. Following the
initial 24h incubation, aliquots of each solution were diluted in LB to monitor bacterial growth over time. For
all materials, the only condition that showed an increased OD over time was the infected-untreated group. No
bacterial growth was detected in the infected/EtO-treated samples for any of the materials. At the 6 h timepoint
the differences between the the infected/untreated and the infected/EtO groups was highly significante (p<0.0001
or p<0.001). Notes: The data are corrected against the O.D. 600 nm of the culture broth at each timepoint. n=3
samples were taken for each condition, which were derived from the same infection event. For all conditions
except HAMA bacterial growth reached stationary phase by 4 hs. Error bars represent standard deviation. (I-L)
Images of infected/untreated, infected/EtO-treated and uninfected/untreated solutions 72 hs after the infection
and treatment. The cloudy appearance of the infected/untreated group indicates the abundance of bacteria. The
uninfected/untreated and infected/EtO-treated groups, in contrast, are clear solutions. Note: The yellow colour
of all solutions arises from LB.
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3.7 Cell Viability within EtO-treated hydrogels
Having established the efficacy of the sterilisation process, our next step was to look for any
detrimental effect of EtO-treated hydrogels on the viability of human cells in culture.
Questions are often raised about latent toxicity of EtO-sterilisation, because EtO is known to
be absorbed by some materials, particularly plastics. Indeed, some polymers sterilised with EtO
have been shown to retain high levels of the chemical even after 15 days of aeration.54 As a
consequence of these concerns, standard protocols for EtO sterilised medical devices designate
steps to ensure removal of residual EtO prior to use and set maximum allowable residue limits
following sterilisation.55,56 The danger of residual EtO is likely mitigated in hydrogels since
EtO reacts with water to produce ethylene glycol, which has negligible cytotoxicity at very low
concentrations.57 Nevertheless, we must also consider the possibility that reactions involving
EtO and hydrogels may produce other cytotoxic by-products.
In this work, we assessed whether the sterilisation process had any adverse effects on cell
viability or proliferation, by performing both 2D and 3D cell culture studies using GelMA as a
representative material.
Firstly, we used the ‘direct contact’ method to assess whether exposure to EtO-treated GelMA
caused any immediate cell morbidity, as may be expected if residual EtO were present.58 The
GelMA used for this experiment was EtO-treated one day before being exposed to the cells,
representing high risk for residual EtO content. hADSCs were seeded in multiwell plates and
cultured for 24 h in proliferation medium. The medium was then removed and replaced by
medium containing 10% w/v of either untreated GelMA or EtO treated GelMA. The hADSCs
were cultured for a further 24 h before being assessed for metabolic activity using the CellTiter
Blue assay. As shown in Figure 7 (A), the numbers of live cells in the untreated GelMA and
EtO-GelMA were similar after this 24h exposure, indicating that the EtO treatment had no
measurable cytotoxic effect at this time point.
We then assessed the proliferation of cells encapsulated in photo-crosslinked GelMA in 3D, as
would be used in the intended bioprinting application. This experiment compared metabolic
activity of MSCs in filtered, autoclaved and EtO-treated GelMA over time in culture. As shown
in Figure 7 (B), the increase in numbers of hMSCs encapsulated in all three GelMA groups did
not show any significant differences in fold-changes by day 7. We conclude that EtO treatment
of GelMA had no significant detrimental impact on the survival of encapsulated hMSCs.
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Figure 7: Viability of human mesenchymal stem cells in GelMA materials in 2D and 3D. (a) The viability of
hMSCs in 2D culture was assessed by a metabolic assay (cell titer blue) after 24h exposure to both untreated and
EtO-treated GelMA at 10% w/v in the culture medium. There was no statistical significance between cell numbers
in the two groups (p=0.65). n=4 for both groups. Cell numbers were calculated based upon a calibration curve
of known cell densities. (b) hMSCs were encapsulated in photocrosslinked GelMA 10% w/v hydrogels (filtered,
autoclaved and EtO-treated) and cultured for one week. Relative cell number was assessed at day 1, 4 and 7 by
metabolic assay (cell titer blue). The increase in cell number was similar in all groups, with no statistically
significant differences between relative cell numbers across any of the three groups by day 7 (n=3).

These results agree with previous work which found no effect of EtO-treated HA on the
viability of either mouse fibrobast (3T3) cells or human coronary venular endothelial cells.58
This was despite the detection of very low levels of EtO residues (2.7×10−2 μg/ml) after a 7day aeration period. Similarly, chitosan-membranes treated with EtO had no cytotoxic effect
on Vero cells.59 In contrast to these studies, an EtO-treated copolymer of (50:50) poly-lacticpolyglycolic acid was determined to be cytotoxic to mouse L929 cells and human fibroblast
cells, even after 14-days degassing under vacuum.60 Clearly, the levels of residual EtO are
highly-dependent on the material being sterilised. In the case of hydrogels, our results and those
previously reported suggest that residual EtO, if any, has no negative affect on cell viability.
3.8

Biofabrication potential: Chondrogenesis of hMSCs within EtO-treated hydrogels

Our final step was to evaluate the potential for EtO-sterilised hydrogels as materials for
biofabrication and tissue engineering. We chose chondrogenic differentiation of human
mesenchymal stem cells and neocartilage formation as an example application. Gelatin,61–63
GelMA,8,16,64–66 HAMA16,64,67 and HA68–71 have all been explored as materials for cartilage
engineering. Informed by the printability tests described in section 3.4 above, a biomaterial
containing 5% w/v gelatin, 5% w/v GelMA and 0.5% w/v HA was formulated for the
chondrogenesis study. All materials were EtO-treated. Owing to the fact that different
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sterilisation methods had varying impacts upon the mechanical properties of the hydrogels
(section 2.6 above) and the challenge of delineating these effects on chondrogenesis of hMSCs,
we did not perform a comparative study of EtO-treated and otherwise treated materials. This
experiment is thus only an illustrative example, which showcases that EtO-treated hydrogels
can be used in an in vitro tissue engineering context.
Based on previous work, we have observed that hADSCs encapsulated in hydrogels showed a
genetic response to chondrogenic stimuli in vitro only after two weeks of culture, followed by
increased expression of chondrogenic markers for up to 8 weeks.35,72 In this study we compared
the standard markers for chondrogenesis (gene expression, GAG content and mechanical
properties) on day 0 and day 26 of culture in chondrogenic medium.
As shown in Figure 8 below, the gene expression levels for key chondrogenic markers were
upregulated during the 26 days of culture in EtO GelMA. On day0, no collagen II expression
was detected, but it was clearly present on day26. In agreement with the increase in collagen
II, there was a three-fold increase in the expression of its upstream regulator SOX-9 on day 26
relative to day 0. Collagen II is a characteristic component of hyaline cartilage tissue,73 while
SOX-9 is the transcription factor responsible for the activation of collagen II expression and
the master regulator of chondrogenesis.74 The expression of collagen II and SOX-9 on day 26
is indicative of hyaline chondrogenesis as previously observed in hydrogels which had been
filter sterilised.35
Glycosaminoglycans (GAG) are an important and characteristic component of cartilage tissue
and play a critical role in cartilage mechanical properties.75 On day 0 and day 26 of
chondrogenesis, scaffolds were digested to detect the content of glycosaminoglycan (GAG)
and DNA. As shown on Figure 8 (d-f), the GAG content showed a 13-fold increase from day
0 (1.20±0.10 ug) to day 26 (16.0±1.96 ug). A 2.5-fold increase in DNA amount was found
when comparing samples from day 0 to day 26, which suggests proliferation during the culture
period. Since DNA amount often remains same for the same cell line, it can also be used as a
reference for cell number.76 The GAG increase was statistically significant after normalization
to the DNA amount. This result complies with our recent study using a similar approach with
filter sterilised GelMA/HAMA and suggests neocartilage formation.35
Mechanical compression tests was also conducted on day0 and day26 of chondrogenesis. As
shown in Figure 8 (g), below, there was an approximately 1.8-fold increase in compressive
modulus from day 0 (~6 kPa) to day 26 (~11kPa), and this increase was statistically significant.
This result supports the finding from gene-expression and GAG analysis that the encapsulated
cells are producing new extracellular matrix (ECM).
28

Confocal imaging performed on day 26 is also shown. Nuclei (white) and actin (red) stainings

were used to localize the position of cells and their polygonal morphology in the hydrogel
scaffolds, while Collagen II (green) staining demonstrates the accumulation of cartilage ECM.
Taken together, the results from RT-qPCR, GAG content, mechanical testing and confocal
microscopy, suggest the seeded hMSC have entered a chondrogenic state within the EtO-treated
hydrogels, consistent with other studies using filter sterilised materials.35,77

Figure 8: Utilisation of EtO-treated materials for a cartilage biofabrication strategy. (a-b) rt-qPCR analysis of
expression of COL2A1 and SOX-9 before and after chondrogenesis. Results are presented as 2e-ΔΔCt in order
to present the fold change in expression at day 26. Since no expression of COL2A1 was detected on day 0, the
fold change in COL2A1 could only be expressed as 1 (c-e) Result of fluorescence assay detecting: (c)
glycosaminoglycan (GAG) content; (d) DNA content and; (e) the GAG/DNA, before and after chondrogenesis.
Content was determined using a calibration curve. (f) Compressive modulus of hydrogels before and after
chondrogenesis. *: p<0.05. (g-i) Confocal microscope images showing staining of: (g) cell nuclei; (h) actin
filament; (i) collagen II. Axis directions arelabelled in G, where z represents the depth of sample. The scanning
was performed from the top surface towards the bottom. Note: light attenuation from top to bottom precluded the
clear analysis of material deeper than ~300 m. Notes: n=3 for (a-f); n=1 for (g-i)
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4

Conclusions

The field of biofabrication is entering a new phase of maturity with pioneering programs of
pre-clinical and clinical trials under way.64,78–80 This phase is marked by new translational
challenges, among them the requirements to demonstrate reliable and effective sterilisation of
materials. In this work, we explored the effect of three sterilisation techniques on four typical
bio-ink components. Our results suggest EtO treatment is the most promising method for
sterilizing bio-ink hydrogels: with a much lower modulation of physical and chemical
properties relative to autoclaving, and being more widely applicable than filter sterilisation. In
a practical example targeting the bio-ink formulation process, we found EtO-sterilised bio-inks
can achieve the standards for printability using far lower hydrogel concentrations than bio-inks
sterilised by other means. Continuing with biological testing of EtO treatment only, we found
that EtO could eradicate a dense bacterial contamination (80 million cells per 0.1g of material)
of all four hydrogels, that it caused no decrease in viability of human MSCs, and nor did it
slow their rate of proliferation. Finally, we demonstrated that EtO-treated biomaterials
supported hMSCs differentiation towards the chondrogenic lineage, and to produce new
cartilage matrix.
In terms of physical, chemical and biological properties, ethylene oxide sterilisation appears to
be a viable option for large-scale sterilisation of these naturally-derived bio-ink hydrogels. It
also has a long history of use with generic implantable medical devices.39 However, the use of
EtO carries the stigma of other risks, in that it is flammable, explosive and carcinogenic. Some
modern EtO processes, such as that explored in this study, minimise these risks by utilising
minute quantities (<5g) of EtO per cycle, as well as various safeguards to ensure the operator
receives negligible exposure to the gas. For additional safety, the system can be set inside a
standard chemical fume hood. These considerations of risk should not be a barrier to adoption
by the field.
This work marks the first study specifically exploring the effects of sterilisation on bio-inks for
3D bioprinting. We have limited the scope of this work to four common bio-ink components,
however many dozens more remain to be explored. Regardless of the methods chosen, every
sterilisation method will have some effect on bio-ink properties, and these effects need to be
documented and discussed within the field.
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